{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:08:31Z","timestamp":1770142111137,"version":"3.49.0"},"reference-count":84,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1080\/1744666x.2023.2282696","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T09:44:38Z","timestamp":1699868678000},"page":"141-153","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA)"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3082-1374","authenticated-orcid":false,"given":"Sho","family":"Fukui","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA, USA"},{"name":"Department of Emergency and General Medicine, Kyorin University School of Medicine, Tokyo, Japan"},{"name":"Immuno-Rheumatology Center, St. Luke\u2019s International Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9457-036X","authenticated-orcid":false,"given":"Satoshi","family":"Kawaai","sequence":"additional","affiliation":[{"name":"Immuno-Rheumatology Center, St. Luke\u2019s International Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2458-5918","authenticated-orcid":false,"given":"Haruki","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Medicine, John A. Burns School of Medicine, University of Hawai\u02bbi, Honolulu, HI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4007-1589","authenticated-orcid":false,"given":"Mitsumasa","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221035"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108233"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001108"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-022-05117-0"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v102.2226"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000589"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/1359105309341394"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2020.01.012"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123582"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1249-1"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2014.10.007"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001752"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00552-4"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637829"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1830512"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215427"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2023.2149494"},{"key":"e_1_3_6_21_1","unstructured":"(FDA) USFaDA PRESCRIBING INFORMATION: Upadacitinib https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/211675s010lbl.pdf accessed on Jun 20 2023."},{"key":"e_1_3_6_22_1","unstructured":"European Medicine Agency (EMA) assessment report; https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/rinvoq [cited 2022 Nov 24]"},{"key":"e_1_3_6_23_1","unstructured":"Pharmaceuticals and Medical Devices Agency (PMDA). Assessment report of upadacitinib in patients with non-radiographic axial spondyloarthritis (in Japanese). https:\/\/www.pmda.go.jp\/drugs\/2023\/P20230222001\/112130000_30200AMX00027_A100_1.pdf accessed on Jun 20 2023."},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab740"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01212-0"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000475"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22831"},{"issue":"3","key":"e_1_3_6_28_1","first-page":"554","article-title":"Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan ankylosing spondylitis Society","volume":"28","author":"Hukuda S","year":"2001","unstructured":"Hukuda S, Minami M, Saito T, et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan ankylosing spondylitis Society. J Rheumatol. 2001;28(3):554\u2013559.","journal-title":"J Rheumatol"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223296"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.154799"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001005"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215934"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41477"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203055"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa685"},{"key":"e_1_3_6_36_1","unstructured":"ClinicalTrials.gov. A study evaluating the effect of Filgotinib in participants with active axial spondyloarthritis (olinguito). https:\/\/beta.clinicaltrials.gov\/study\/NCT05785611?distance=50&cond=Axial%20Spondyloarthritis%20%5C(axSpA%5C)&rank=1&intr=Filgotinib accessed on Jun 20 2023."},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.685280"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223595"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213328"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40728"},{"key":"e_1_3_6_41_1","unstructured":"ClinicalTrials.gov. Efficacy and safety of namilumab for moderate-to-severe axial spondyloarthritis (NAMASTE). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03622658 accessed on Jun 20 2023."},{"key":"e_1_3_6_42_1","unstructured":"ClinicalTrials.gov. ABY-035 in the treatment of subjects with ankylosing spondylitis: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04795141 accessed on Jun 28 2023"},{"key":"e_1_3_6_43_1","unstructured":"ClinicalTrials.gov. International multicenter comparative randomized placebo-controlled clinical study of efficacy and safety of BCD-085 in patients with ankylosing spondylitis. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03447704 accessed on Jun 28 2023."},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102307"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00726-8"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac551"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208840"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18922"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1544892"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39808"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39801"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31115-2"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31116-4"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41032"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32534-6"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222608"},{"issue":"12","key":"e_1_3_6_57_1","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease Activity Index","volume":"21","author":"Garrett S","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease Activity Index. J Rheumatol. 1994;21(12):2286\u20132291.","journal-title":"J Rheumatol"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-023-00550-4"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.1.20"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203967"},{"key":"e_1_3_6_61_1","first-page":"877","article-title":"POS1108\u2005EFFICACY of UPADACITINIB in PATIENTS with NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS in EARLY versus ESTABLISHED DISEASE","volume":"82","author":"Navarro-Comp\u00e1n V","year":"2023","unstructured":"Navarro-Comp\u00e1n V, van den Bosch F, Sampaio-Barros PD, et al. POS1108\u2005EFFICACY of UPADACITINIB in PATIENTS with NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS in EARLY versus ESTABLISHED DISEASE. Ann Rheumatic Dis. 2023;82:877\u2013878.","journal-title":"Ann Rheumatic Dis"},{"key":"e_1_3_6_62_1","first-page":"361","article-title":"POS0250\u2005PLACEBO-CONTROLLED EFFICACY and SAFETY of UPADACITINIB THROUGH ONE YEAR in PATIENTS with NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS","volume":"82","author":"van den Bosch F","year":"2023","unstructured":"van den Bosch F, Deodhar A, Poddubnyy D, et al. POS0250\u2005PLACEBO-CONTROLLED EFFICACY and SAFETY of UPADACITINIB THROUGH ONE YEAR in PATIENTS with NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS. Ann Rheumatic Dis. 2023;82:361\u2013362.","journal-title":"Ann Rheumatic Dis"},{"key":"e_1_3_6_63_1","unstructured":"ClinicalTrials.gov. A study to assess disease Activity in adult participants with axial spondyloarthritis who receive upadacitinib in a real-world setting (UpSPINE). https:\/\/beta.clinicaltrials.gov\/study\/NCT05094128?distance=50&cond=upadacitinib&rank=1&term=axSpA accessed on Jun 20 2023."},{"key":"e_1_3_6_64_1","unstructured":"ClinicalTrials.gov. A study of the change in early and sustained pain control in radiographic axial spondylarthritis in adult participants receiving upadacitinib (UPSTAND). https:\/\/beta.clinicaltrials.gov\/study\/NCT04846244?distance=50&cond=upadacitinib&rank=2&term=axSpA accessed on Jun 20 2023."},{"key":"e_1_3_6_65_1","unstructured":"ClinicalTrials.gov. A study of oral upadacitinib (RINVOQ) tablets to assess adverse events and change in disease symptoms in Korean participants with moderate to severe active rheumatoid arthritis atopic dermatitis ankylosing spondylitis or psoriatic arthritis. https:\/\/beta.clinicaltrials.gov\/study\/NCT04541810?distance=50&cond=upadacitinib&rank=4&term=axSpA accessed on Jun 20 2023.;"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11151"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01384-8"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key225"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0825-9"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31946-9"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141278"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.2312"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224232"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38721"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201766"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39257"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00789-1"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.33"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-022-05073-7"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002735"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key208"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14108"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109927"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222259"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223715"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224049"}],"updated-by":[{"DOI":"10.1080\/1744666x.2024.2309754","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000}}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2023.2282696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T04:55:41Z","timestamp":1727240141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2023.2282696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1080\/1744666X.2023.2282696"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2023.2282696","relation":{"correction":[{"id-type":"doi","id":"10.1080\/1744666X.2024.2309754","asserted-by":"object"}]},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-07-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}